Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 5 | 2023 | 106 | 0.860 |
Why?
|
| Genetic Predisposition to Disease | 15 | 2023 | 528 | 0.750 |
Why?
|
| Lymphocytes | 1 | 2019 | 116 | 0.660 |
Why?
|
| Neutrophils | 1 | 2019 | 124 | 0.660 |
Why?
|
| Genome-Wide Association Study | 8 | 2023 | 271 | 0.620 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 147 | 0.590 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 195 | 0.570 |
Why?
|
| Colorectal Neoplasms | 6 | 2015 | 413 | 0.400 |
Why?
|
| DNA Mismatch Repair | 4 | 2012 | 24 | 0.400 |
Why?
|
| Germ-Line Mutation | 3 | 2020 | 51 | 0.380 |
Why?
|
| Breast Neoplasms | 7 | 2020 | 1426 | 0.360 |
Why?
|
| Glucuronosyltransferase | 2 | 2019 | 25 | 0.330 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2019 | 32 | 0.330 |
Why?
|
| Genotype | 7 | 2020 | 641 | 0.280 |
Why?
|
| Registries | 7 | 2020 | 330 | 0.270 |
Why?
|
| Polymorphism, Single Nucleotide | 10 | 2023 | 638 | 0.270 |
Why?
|
| Colonic Neoplasms | 3 | 2013 | 181 | 0.270 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 3 | 2012 | 18 | 0.260 |
Why?
|
| Aged | 15 | 2020 | 6448 | 0.230 |
Why?
|
| Humans | 30 | 2023 | 34853 | 0.210 |
Why?
|
| Neoplasm Staging | 3 | 2019 | 269 | 0.210 |
Why?
|
| Middle Aged | 16 | 2020 | 9642 | 0.210 |
Why?
|
| Female | 23 | 2020 | 19873 | 0.200 |
Why?
|
| Odds Ratio | 3 | 2019 | 517 | 0.190 |
Why?
|
| Nicotine | 1 | 2023 | 238 | 0.190 |
Why?
|
| Receptors, Calcitriol | 1 | 2019 | 59 | 0.170 |
Why?
|
| Nitrosamines | 1 | 2018 | 9 | 0.160 |
Why?
|
| Glucuronides | 1 | 2018 | 10 | 0.160 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 133 | 0.160 |
Why?
|
| Male | 17 | 2019 | 18870 | 0.160 |
Why?
|
| Estrogen Receptor beta | 2 | 2008 | 37 | 0.160 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 570 | 0.150 |
Why?
|
| Genetic Variation | 3 | 2008 | 328 | 0.150 |
Why?
|
| Mutation | 3 | 2012 | 1023 | 0.140 |
Why?
|
| DNA-Binding Proteins | 4 | 2013 | 522 | 0.140 |
Why?
|
| Lung Neoplasms | 2 | 2011 | 336 | 0.140 |
Why?
|
| Case-Control Studies | 6 | 2020 | 1056 | 0.140 |
Why?
|
| Logistic Models | 3 | 2019 | 894 | 0.140 |
Why?
|
| Adiposity | 1 | 2017 | 145 | 0.140 |
Why?
|
| Risk Factors | 9 | 2020 | 3414 | 0.140 |
Why?
|
| DNA Repair | 2 | 2008 | 181 | 0.140 |
Why?
|
| Ovarian Neoplasms | 1 | 2019 | 303 | 0.130 |
Why?
|
| CpG Islands | 1 | 2015 | 91 | 0.130 |
Why?
|
| Obesity | 2 | 2023 | 965 | 0.120 |
Why?
|
| DNA Repair Enzymes | 1 | 2013 | 20 | 0.120 |
Why?
|
| Aged, 80 and over | 7 | 2020 | 2333 | 0.120 |
Why?
|
| 3' Untranslated Regions | 1 | 2013 | 67 | 0.120 |
Why?
|
| Retrospective Studies | 1 | 2019 | 1961 | 0.110 |
Why?
|
| Adenosine Triphosphatases | 1 | 2013 | 78 | 0.110 |
Why?
|
| Haplotypes | 3 | 2008 | 152 | 0.110 |
Why?
|
| Gene Deletion | 1 | 2013 | 156 | 0.110 |
Why?
|
| Smoking | 2 | 2010 | 903 | 0.110 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2012 | 14 | 0.110 |
Why?
|
| Survivors | 1 | 2013 | 126 | 0.110 |
Why?
|
| Exercise | 1 | 2017 | 524 | 0.110 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2013 | 85 | 0.110 |
Why?
|
| DNA Methylation | 1 | 2015 | 301 | 0.100 |
Why?
|
| Cohort Studies | 5 | 2020 | 1422 | 0.100 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2010 | 4 | 0.100 |
Why?
|
| Receptors, Somatostatin | 1 | 2010 | 5 | 0.100 |
Why?
|
| Carrier Proteins | 2 | 2010 | 287 | 0.100 |
Why?
|
| Prostatic Neoplasms | 2 | 2010 | 794 | 0.100 |
Why?
|
| Genomic Imprinting | 1 | 2010 | 35 | 0.100 |
Why?
|
| Computational Biology | 1 | 2012 | 275 | 0.090 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2010 | 66 | 0.090 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2009 | 1 | 0.090 |
Why?
|
| Glycoproteins | 1 | 2010 | 100 | 0.090 |
Why?
|
| DNA Glycosylases | 1 | 2008 | 16 | 0.090 |
Why?
|
| Databases, Genetic | 2 | 2020 | 90 | 0.090 |
Why?
|
| Adult | 10 | 2020 | 11034 | 0.080 |
Why?
|
| Asthma | 1 | 2011 | 363 | 0.080 |
Why?
|
| Microsatellite Instability | 3 | 2012 | 43 | 0.070 |
Why?
|
| Polymorphism, Genetic | 1 | 2008 | 165 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2008 | 239 | 0.070 |
Why?
|
| Cell Cycle Proteins | 1 | 2008 | 220 | 0.070 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2006 | 2 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 1 | 2007 | 455 | 0.070 |
Why?
|
| Linkage Disequilibrium | 2 | 2021 | 58 | 0.070 |
Why?
|
| Chromosomal Instability | 1 | 2005 | 21 | 0.070 |
Why?
|
| Prognosis | 3 | 2013 | 707 | 0.070 |
Why?
|
| Receptors, Androgen | 1 | 2006 | 122 | 0.060 |
Why?
|
| Morbidity | 1 | 2004 | 94 | 0.060 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2023 | 8 | 0.060 |
Why?
|
| Cause of Death | 1 | 2004 | 154 | 0.060 |
Why?
|
| Family Health | 2 | 2015 | 47 | 0.060 |
Why?
|
| Butyric Acid | 1 | 2023 | 17 | 0.060 |
Why?
|
| Cotinine | 1 | 2023 | 40 | 0.060 |
Why?
|
| Life Style | 1 | 2004 | 288 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 781 | 0.050 |
Why?
|
| Neoplasm Proteins | 2 | 2019 | 203 | 0.050 |
Why?
|
| Chromatography, Liquid | 1 | 2023 | 140 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2023 | 173 | 0.050 |
Why?
|
| Young Adult | 3 | 2020 | 4012 | 0.050 |
Why?
|
| United States | 3 | 2019 | 3894 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2013 | 430 | 0.050 |
Why?
|
| Risk Assessment | 3 | 2010 | 727 | 0.050 |
Why?
|
| Quantitative Trait Loci | 1 | 2020 | 68 | 0.050 |
Why?
|
| Genetic Testing | 1 | 2020 | 71 | 0.050 |
Why?
|
| Family | 2 | 2013 | 162 | 0.050 |
Why?
|
| Genome, Human | 1 | 2021 | 112 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 115 | 0.050 |
Why?
|
| Pedigree | 2 | 2013 | 64 | 0.050 |
Why?
|
| MutS Homolog 2 Protein | 2 | 2012 | 30 | 0.040 |
Why?
|
| Microsatellite Repeats | 2 | 2012 | 51 | 0.040 |
Why?
|
| Follistatin | 1 | 2019 | 27 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2019 | 56 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2019 | 91 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 102 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2021 | 347 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 859 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2018 | 2 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2018 | 5 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2019 | 171 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2021 | 1802 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2012 | 180 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2018 | 121 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 901 | 0.040 |
Why?
|
| Gene Expression | 1 | 2020 | 639 | 0.040 |
Why?
|
| Waist-Hip Ratio | 1 | 2017 | 32 | 0.040 |
Why?
|
| Nuclear Proteins | 2 | 2012 | 287 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 89 | 0.040 |
Why?
|
| Heterozygote | 2 | 2008 | 91 | 0.040 |
Why?
|
| Vitamin D | 1 | 2019 | 176 | 0.040 |
Why?
|
| Waist Circumference | 1 | 2017 | 82 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 184 | 0.040 |
Why?
|
| Risk | 2 | 2008 | 256 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2018 | 226 | 0.030 |
Why?
|
| Proteins | 1 | 2018 | 352 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 2128 | 0.030 |
Why?
|
| Adolescent | 2 | 2020 | 5035 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2017 | 775 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 213 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2012 | 59 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 89 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2012 | 23 | 0.030 |
Why?
|
| Linear Models | 1 | 2013 | 253 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2012 | 82 | 0.030 |
Why?
|
| Phenotype | 1 | 2015 | 650 | 0.030 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2011 | 4 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2012 | 91 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 423 | 0.030 |
Why?
|
| ROC Curve | 1 | 2012 | 138 | 0.030 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2010 | 22 | 0.020 |
Why?
|
| Fathers | 1 | 2010 | 26 | 0.020 |
Why?
|
| DNA | 1 | 2013 | 549 | 0.020 |
Why?
|
| Age of Onset | 1 | 2010 | 98 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2011 | 176 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 445 | 0.020 |
Why?
|
| Incidence | 1 | 2011 | 882 | 0.020 |
Why?
|
| Australia | 1 | 2008 | 76 | 0.020 |
Why?
|
| Canada | 1 | 2008 | 121 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 1681 | 0.020 |
Why?
|
| Mothers | 1 | 2010 | 164 | 0.020 |
Why?
|
| Exons | 1 | 2007 | 80 | 0.020 |
Why?
|
| Age Factors | 1 | 2010 | 1007 | 0.020 |
Why?
|
| Alleles | 1 | 2008 | 284 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2008 | 429 | 0.020 |
Why?
|
| Base Pair Mismatch | 1 | 2005 | 13 | 0.020 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2005 | 9 | 0.020 |
Why?
|
| SEER Program | 1 | 2005 | 87 | 0.020 |
Why?
|
| Neoplasms | 2 | 2005 | 1033 | 0.020 |
Why?
|
| Pacific Islands | 1 | 2004 | 115 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 229 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2004 | 231 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2006 | 1353 | 0.010 |
Why?
|
| Mass Screening | 1 | 2005 | 427 | 0.010 |
Why?
|
| Risk-Taking | 1 | 2004 | 435 | 0.010 |
Why?
|
| Prevalence | 1 | 2004 | 1425 | 0.010 |
Why?
|
| Hawaii | 1 | 2004 | 1878 | 0.010 |
Why?
|